UCB's goal is to command a leading position in discovering and developing new therapies to treat patients suffering from severe diseases. With a strong pipeline, our focus is on central nervous system (CNS) disorders and immunology diseases to provide new treatments for specialists and their patients.
Our philosophy is to have a "one team" approach to drug discovery and development with seamless integration of research, development and commercial colleagues, in a process of continual learning and confirming as we examine our data and capitalize on our knowledge.
More information on UCB global research and development on the
UCB Corporate Web site.